Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-α-D3

Annals of Clinical Biochemistry

Volumn 42, Issue 1, 2005, Pages 55-60

  Stefanovic, Vladisav ^a   Djordjevic, V ^a   Ivic, M ^a   Mitic Zlatkovic, M ^a   Vlahovic, P ^a  

^a UNIVERSITY OF NI   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CELL ANTIGEN; CONCANAVALIN A; GLUCOSE; HEMOGLOBIN; INSULIN RECEPTOR KINASE; PARATHYROID HORMONE; PHORBOL 12 ACETATE 13 MYRISTATE; PLASMA CELL DIFFERENTIATION ANTIGEN 1; PROTEIN TYROSINE KINASE; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG PULSE THERAPY; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INSULIN RESISTANCE; KIDNEY FAILURE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MAINTENANCE THERAPY; MALE; MUSCLE TISSUE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; UREMIA;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ADULT; AGED; BLOOD GLUCOSE; CARCINOGENS; CONCANAVALIN A; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; HYDROXYCHOLECALCIFEROLS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; RENAL DIALYSIS; TETRADECANOYLPHORBOL ACETATE;

EID: 13444310488     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563053026790     Document Type: Article

References (19)

1. De Fronzo RA, Smith D, Alvestrand A. Insulin action in uraemia. Kidney Int 1983; 6(Suppl 24): S102-14
2. Smith D, DeFronzo RA. Insulin resistance in uraemia mediated by post-binding defects. Kidney Int 1982; 22: 54-62
3. Borissova AM, Djambazova A, Todorov K, Dakovska L, Tankova T, Kirilov G. Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on haemodialysis. Nephrol Dial Transplant 1993; 8: 93-5
4. Mak RHK. Correction of anaemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uraemia. Am J Physiol 1996; 270: F839-94
5. Allegra V, Mengozzi G, Martimbianco L, Vasile A. Early and late effects of erythropoietin on glucose metabolism in maintenance haemodialysis patients. Am J Nephrol 1996; 16: 304-8
6. Kautzky-Willer A, Pacini G, Barnas U, et al. Intravenous calcitriol normalizes insulin sensitivity in uraemic patients. Kidney Int 1995; 47: 200-6
7. Mak RHK. 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uraemia. Kidney Int 1998; 53: 1353-7
8. Maddux BA, Sbraccia P, Kumakura S, et al. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 1995; 373: 448-51
9. Frittitta L, Youngren J, Vigneri R, Maddux BA, Trischitta V, Goldfine ID. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity. Diabetologia 1996; 39: 1190-5
10. Frittitta L, Spampinato D, Solini A, et al. Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in non-diabetic subjects. Evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling. Diabetes 1998; 47: 1095-100
11. Stefanovic V, Antic S, Mitic-Zlatkovic M, Vlahovic P. Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin. Diabetes Metab Res Rev 1999; 15: 400-4
12. Stefanovic V, Golubovic E, Vlahovic P, Mitic-Zlatkovic M. Lymphocyte ectoenzymes in childhood idiopathic nephrotic syndrome. Pediatr Nephrol 1998; 12: 755-60
13. Foss MC, Gouveia LM, Moyses Neto M, Paccola GM, Piccinato CE. Effect of haemodialysis on peripheral glucose metabolism of patients with chronic renal failure. Nephron 1996; 73: 48-53
14. Kobayashi S, Maejima S, Ikeda T, Nagase M. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2000; 15: 65-70
15. Spaia S, Pangalos M, Askepidis N, et al. Effect of short-term rHuEPO treatment on insulin resistance in haemodialysis patients. Nephron 2000; 84: 320-5
16. Djordjević V, Radivojević J, Stefanović V. Improvement of anaemia in haemodialysis patients after pulse oral 1-α-D3 treatment. Clin Nephrol 2002; 57: 487-8
17. Mak RHK. Effect of metabolic acidosis on insulin action and secretion in uraemia. Kidney Int 1998; 54: 603-7
18. Billaudel BJ, Bourlon PM, Sutler BC, Faure-Dussert AG. Regulatory effect of 1,25-dihydroxyvitamin D3 on insulin release and calcium handling via the phospholipid pathway in islets from vitamin D-deficient rats. J Endocrinol Invest 1995; 18: 673-82
19. Tokuda N, Kano M, Meiri H, Nomoto K, Naito S. Calcitriol therapy modulates the cellular immune responses in haemodialysis patients. Am J Nephrol 2000; 20: 129-37